3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Leukemia, Monocytic, Acute
2
Leukemia, Biphenotypic, Acute
2
Hodgkin Disease
2
Teratoma
1
Solid Tumors
1
Sarcoma, Myeloid
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Lymphoma, Non-Hodgkin
1
Lymphoma, AIDS-Related
1
Leukemia, Plasma Cell
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphoid
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Choriocarcinoma
1
Carcinoma, Embryonal
1
Burkitt Lymphoma
1
Anemia, Refractory, with Excess of Blasts
1
Adenocarcinoma, Bronchiolo-Alveolar
1
Adenocarcinoma of Lung
1
Interventions
Rituximab
44
Cyclophosphamide
38
Prednisone
26
Doxorubicin
25
Vincristine
20
Magnetic Resonance Spectroscopy
20
Lenalidomide
19
Specimen Handling
18
Gemcitabine
18
Biopsy
15
polatuzumab vedotin
14
Oxaliplatin
14
glofitamab
12
obinutuzumab
11
ibrutinib
10
Etoposide
10
CT-P10
9
fludarabine
8
Dexamethasone
8
prednylidene
7
pembrolizumab
7
deltacortene
7
Prednisolone
7
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
7
venetoclax
6
tafasitamab
6
acalabrutinib
6
fludarabine phosphate
5
R-CHOP protocol
5
Immunotherapy, Adoptive
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
pegylated granulocyte colony-stimulating factor
×
90 days
×
Clear all
No trials found.